The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant.
Treatment of mood disorders in pregnant or nursing women can carry significant risks for the mother and the developing infant. For patients and physicians, it may be difficult to obtain current information to make the proper decisions regarding pharmacologic and alternative treatments. Thus, this paper discusses the risks and benefits of pharmacologic treatment and the risks of not treating depression and bipolar disorder in the pregnant woman. The safety of treatment options is reviewed. Alternative treatment options are also discussed.
Kloos
Angelica L
AL
Department of Child and Adolescent Psychiatry, Children's National Medical Center, 111 Michigan Avenue, NW, Suite 1200, Washington, DC 20010, USA. akloos@cnmc.org
Dubin-Rhodin
Abigail
A
Sackett
Jillan Cantor
JC
Dixon
Thomas A
TA
Weller
Ronald A
RA
Weller
Elizabeth B
EB
D000928:Antidepressive Agents / Q000009:adverse effects*; D018692:Antimanic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D019964:Mood Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D000928:Antidepressive Agents; D018692:Antimanic Agents